Subscribe

Subscribe

Latest Content

Solar

Storage

Wind

Event Spotlight

BLOGS

DISTRIBUTECH+ RECAP: Energy Storage Utility Case Studies

Webcast

OPINION

RESOURCES

CLARION ENERGY MEDIA

POWER & ENERGY EVENT SERIES

Privacy Policy

Copyright © 2019 - 2021

Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

81.73 -3.20 (-3.76%)
Streaming Delayed Price Updated: 1:25 PM EDT, Aug 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,381,238
Open 85.00
Bid (Size) 81.71 (1)
Ask (Size) 81.76 (2)
Prev. Close 84.93
Today's Range 81.47 - 85.00
52wk Range 62.55 - 170.47
Shares Outstanding 384,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Market Whales and Their Recent Bets on MRNA Options
Via Benzinga
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire

Performance

YTD
-27.35%
-27.35%
1 Month
-32.71%
-32.71%
3 Month
-34.96%
-34.96%
6 Month
-8.16%
-8.16%
1 Year
-18.27%
-18.27%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Expanding the Cloud for AI
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
What the Options Market Tells Us About Moderna
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,300 Today
Via Benzinga
3 Undervalued Stocks With Room to Rally Even Higher
Via InvestorPlace
Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again.
Via Investor's Business Daily
Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
Via Benzinga
Exposures COVID-19
MicroStrategy, Intel And Moderna Are Among Top 12 Large Cap Losers Last Week (July 28-August 3): Are The Others In Your Portfolio?
Via Benzinga
Moderna's Ongoing Decline
Via Talk Markets
Cathie Wood Bought This Stock After Its 27% Drop. Should You?
Via The Motley Fool
Where Will Novavax Be in 5 Years?
Via The Motley Fool
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
Via Benzinga
Exposures COVID-19
Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood's Ark Adds Over $19M Worth Of Moderna Shares After Thursday's 21% Plunge On Guidance Cut
Via Benzinga
3 AI-Powered Healthcare Stocks Transforming Medicine
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
US Stocks Close Lower As Apple, Amazon Report Earnings: Greed Index Moves To 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
MRNA Investors Have Opportunity to Join Moderna, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Crude Oil Moves Lower; Moderna Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Stock Of The Day: Moderna Stock Plunges, Breaking Key Support Levels Following Earnings Report
Via Benzinga
Moderna (MRNA) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Stocks To Watch Today: MRNA, META, And AMAT
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Moderna CEO Stephane Bancel On Q2 Results, Slashing Its Full-Year Sales Guidance
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.